Hangzhou Coco Healthcare Products Co Ltd
SZSE:301009
Hangzhou Coco Healthcare Products Co Ltd
Cost of Revenue
Hangzhou Coco Healthcare Products Co Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Hangzhou Coco Healthcare Products Co Ltd
SZSE:301009
|
Cost of Revenue
-¥1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Blue Moon Group Holdings Ltd
HKEX:6993
|
Cost of Revenue
-HK$2.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Opple Lighting Co Ltd
SSE:603515
|
Cost of Revenue
-¥4.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai Feilo Acoustics Co Ltd
SSE:600651
|
Cost of Revenue
-¥1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
7%
|
CAGR 10-Years
0%
|
C
|
C&S Paper Co Ltd
SZSE:002511
|
Cost of Revenue
-¥6.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-13%
|
S
|
Shenzhen Hello Tech Energy Co Ltd
SZSE:301327
|
Cost of Revenue
-¥1.4B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Hangzhou Coco Healthcare Products Co Ltd's Cost of Revenue?
Cost of Revenue
-1B
CNY
Based on the financial report for Dec 31, 2022, Hangzhou Coco Healthcare Products Co Ltd's Cost of Revenue amounts to -1B CNY.
What is Hangzhou Coco Healthcare Products Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-7%
Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for Hangzhou Coco Healthcare Products Co Ltd have been -7% over the past three years .